These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11768830)

  • 1. Use of OncoScint scan to assess resectability of hepatic metastases from colorectal cancer.
    Su WT; Brachman M; O'Connell TX
    Am Surg; 2001 Dec; 67(12):1200-3. PubMed ID: 11768830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter clinical trials of monoclonal antibody B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR103) in patients with colorectal carcinoma.
    Abdel-Nabi HH; Doerr RJ
    Targeted Diagn Ther; 1992; 6():73-88. PubMed ID: 1576351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations.
    Bohdiewicz PJ; Scott GC; Juni JE; Fink-Bennett D; Wilner F; Nagle C; Dworkin HJ
    Clin Nucl Med; 1995 Mar; 20(3):230-6. PubMed ID: 7750217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of surgical resectability in patients with hepatic colorectal metastases.
    Vogel SB; Drane WE; Ros PR; Kerns SR; Bland KI
    Ann Surg; 1994 May; 219(5):508-14; discussion 514-6. PubMed ID: 8185401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease.
    Jarnagin WR; Fong Y; Ky A; Schwartz LH; Paty PB; Cohen AM; Blumgart LH
    J Am Coll Surg; 1999 Jan; 188(1):33-42. PubMed ID: 9915240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunodetection of colorectal carcinoma.
    Artiko V; Obradovic V; Davidovic B; Petrovic N; Petrovic M; Krivokapic Z; Kecmanovic D; Pesko P; Djukic V; Milosavljevic T; Adanja G; Vlajkovic M
    Hepatogastroenterology; 2003; 50(52):1029-31. PubMed ID: 12845972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature.
    Pinkas L; Robins PD; Forstrom LA; Mahoney DW; Mullan BP
    Nucl Med Commun; 1999 Aug; 20(8):689-96. PubMed ID: 10451876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OncoScint CR103 imaging in the surgical management of patients with colorectal cancer.
    Doerr RJ; Abdel-Nabi HH
    Targeted Diagn Ther; 1992; 6():89-109. PubMed ID: 1576352
    [No Abstract]   [Full Text] [Related]  

  • 9. [Indium 111-labeled antibodies in the detection of colorectal carcinoma].
    Artiko V; Obradović V; Davidović B; Petrović N; Petrović M; Krivokapić Z; Pavlov M; Adanja G; Sobić D; Vlajković M; Pavlović S; Rebić R
    Acta Chir Iugosl; 2003; 50(4):43-6. PubMed ID: 15307496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopy in the management of colorectal cancer metastatic to the liver.
    Koea J; Rodgers M; Thompson P; Woodfield J; Holden A; McCall J
    ANZ J Surg; 2004 Dec; 74(12):1056-9. PubMed ID: 15574147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncoscint for detection of disseminated colorectal and ovarian cancer.
    Med Lett Drugs Ther; 1993 Jun; 35(898):52-3. PubMed ID: 8497207
    [No Abstract]   [Full Text] [Related]  

  • 12. False-positive imaging of In-111 labeled monoclonal antibody conjugate CYT-103 in a patient with metastatic colorectal carcinoma.
    Bhatia M; Baron PL; Alderman DF; Gordon L
    Clin Nucl Med; 1995 Nov; 20(11):979-80. PubMed ID: 8565379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy.
    Raderer M; Becherer A; Kurtaran A; Angelberger P; Li S; Leimer M; Weinlaender G; Kornek G; Kletter K; Scheithauer W; Virgolini I
    J Nucl Med; 1996 Sep; 37(9):1480-7. PubMed ID: 8790198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of staging laparoscopy prior to hepatic resection for colorectal metastases.
    Khan AZ; Karanjia ND
    Eur J Surg Oncol; 2007 Oct; 33(8):1010-3. PubMed ID: 17267165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OncoScint image atlas.
    Maguire RT
    Targeted Diagn Ther; 1992; 6():141-75. PubMed ID: 1576344
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative analysis of In-111 satumomab pendetide immunoscintigraphy. An aid to visual interpretation of images in patients with suspected carcinomatosis.
    Neal CE; Johnson DL; Cornwell VL; Markwell S
    Clin Nucl Med; 1996 Aug; 21(8):638-42. PubMed ID: 8853918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of laparoscopic staging for patients with colorectal metastases.
    Metcalfe MS; Close JS; Iswariah H; Morrison C; Wemyss-Holden SA; Maddern GJ
    Arch Surg; 2003 Jul; 138(7):770-2. PubMed ID: 12860759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site of mistletoe injection observed on In-111 OncoScint imaging.
    Choe W
    Clin Nucl Med; 1997 Feb; 22(2):127. PubMed ID: 9031776
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of FDG-PET in the selection of patients with colorectal liver metastases.
    Wiering B; Krabbe PF; Dekker HM; Oyen WJ; Ruers TJ
    Ann Surg Oncol; 2007 Feb; 14(2):771-9. PubMed ID: 17086488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of laparoscopy versus laparotomy for initial surgical evaluation and treatment of potentially resectable hepatic colorectal metastases: a decision analysis.
    Karuna ST; Thirlby R; Biehl T; Veenstra D
    J Surg Oncol; 2008 Apr; 97(5):396-403. PubMed ID: 18270972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.